MRI-Guided Neurosurgical Ablation Market Size, Share & Trends Analysis Report 2024-2032

The Global MRI-Guided Neurosurgical Ablation Market Size accounted for USD 628.9 Million in 2023 and is estimated to achieve a market size of USD 1,166.7 Million by 2032 growing at a CAGR of 7.2% from 2024 to 2032.

The MRI-guided neurosurgical ablation market represents a rapidly evolving sector within the field of medical technology, combining advanced imaging techniques with therapeutic interventions to treat various neurological conditions. Neurosurgical ablation refers to the process of removing or destroying abnormal brain tissue, such as tumors or other diseased areas, using targeted energy sources such as radiofrequency, laser, or focused ultrasound. MRI-guided neurosurgical ablation enhances the precision and effectiveness of these procedures by employing magnetic resonance imaging (MRI) to visualize the brain in real time, allowing for optimal targeting and minimal damage to healthy tissue. This abstract explores the key market drivers, current trends, challenges, and future growth opportunities in the MRI-guided neurosurgical ablation industry.

The primary market drivers for MRI-guided neurosurgical ablation are the rising prevalence of neurological disorders, technological advancements in MRI and ablation techniques, and the increasing demand for minimally invasive surgical procedures. Neurological conditions such as brain tumors, epilepsy, Parkinson's disease, and arteriovenous malformations (AVMs) are becoming more prevalent globally, particularly with an aging population and improvements in diagnostic capabilities that allow for earlier detection. The demand for effective treatments for these conditions has spurred growth in the field of neurosurgery, with MRI-guided ablation emerging as a promising technique for non-invasive or minimally invasive intervention.

MRI-Guided Neurosurgical Ablation Market Segmentation

The worldwide market for MRI-guided neurosurgical ablation is split based on product, end use, and geography.


MRI-Guided Neurosurgical Ablation Market By Product

Accessories
MRI-Guided Laser Ablation Systems
MRI-Guided Focused Ultrasound Systems
MRI-Guided Radiofrequency Ablation Systems

MRI-Guided Neurosurgical Ablation Market By End Use

Clinics
Ambulatory Surgical Centers
Hospitals

MRI-Guided Neurosurgical Ablation Market Regional Outlook

North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Rest of Europe
Asia-Pacific
India
Japan
China
Australia
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
The Middle East & Africa
South Africa
GCC Countries
Rest of the Middle East & Africa (ME&A)

MRI-Guided Neurosurgical Ablation Market Players

Some of the top MRI-guided neurosurgical ablation companies offered in our report include Hitachi Medical Systems, AngioDynamics, Varian Medical Systems, Abbott Laboratories, MRI Interventions, Inc., Boston Scientific Corporation, MR Solutions, Monteris Medical, InSightec Ltd., Medtronic, and Elekta AB.


CHAPTER 1. Industry Overview of MRI-Guided Neurosurgical Ablation Market
1.1. Definition and Scope
1.1.1. Definition of MRI-Guided Neurosurgical Ablation
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global MRI-Guided Neurosurgical Ablation Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. MRI-Guided Neurosurgical Ablation Market By Product
1.2.3. MRI-Guided Neurosurgical Ablation Market By End Use
1.2.4. MRI-Guided Neurosurgical Ablation Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of MRI-Guided Neurosurgical Ablation Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for MRI-Guided Neurosurgical Ablation Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2023
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023
4.2. R&D Status of Major Manufacturers in 2023
CHAPTER 5. MRI-Guided Neurosurgical Ablation Market By Product
5.1. Introduction
5.2. MRI-Guided Neurosurgical Ablation Revenue By Product
5.2.1. MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast, By Product, 2020-2032
5.2.2. Accessories
5.2.2.1. Accessories Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. MRI-guided Laser Ablation Systems
5.2.3.1. MRI-guided Laser Ablation Systems Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. MRI-guided Focused Ultrasound Systems
5.2.4.1. MRI-guided Focused Ultrasound Systems Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5. MRI-guided Radiofrequency Ablation Systems
5.2.5.1. MRI-guided Radiofrequency Ablation Systems Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. MRI-Guided Neurosurgical Ablation Market By End Use
6.1. Introduction
6.2. MRI-Guided Neurosurgical Ablation Revenue By End Use
6.2.1. MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast, By End Use, 2020-2032
6.2.2. Clinics
6.2.2.1. Clinics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Ambulatory Surgical Centers
6.2.3.1. Ambulatory Surgical Centers Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.4. Hospitals
6.2.4.1. Hospitals Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. North America MRI-Guided Neurosurgical Ablation Market By Country
7.1. North America MRI-Guided Neurosurgical Ablation Market Overview
7.2. U.S.
7.2.1. U.S. MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
7.2.2. U.S. MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
7.3. Canada
7.3.1. Canada MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
7.3.2. Canada MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
7.4. North America PEST Analysis
CHAPTER 8. Europe MRI-Guided Neurosurgical Ablation Market By Country
8.1. Europe MRI-Guided Neurosurgical Ablation Market Overview
8.2. U.K.
8.2.1. U.K. MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
8.2.2. U.K. MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
8.3. Germany
8.3.1. Germany MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
8.3.2. Germany MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
8.4. France
8.4.1. France MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
8.4.2. France MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
8.5. Spain
8.5.1. Spain MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
8.5.2. Spain MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
8.6. Rest of Europe
8.6.1. Rest of Europe MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
8.6.2. Rest of Europe MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific MRI-Guided Neurosurgical Ablation Market By Country
9.1. Asia Pacific MRI-Guided Neurosurgical Ablation Market Overview
9.2. China
9.2.1. China MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
9.2.2. China MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
9.3. Japan
9.3.1. Japan MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
9.3.2. Japan MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
9.4. India
9.4.1. India MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
9.4.2. India MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
9.5. Australia
9.5.1. Australia MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
9.5.2. Australia MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
9.6. South Korea
9.6.1. South Korea MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
9.6.2. South Korea MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
9.7.2. Rest of Asia-Pacific MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America MRI-Guided Neurosurgical Ablation Market By Country
10.1. Latin America MRI-Guided Neurosurgical Ablation Market Overview
10.2. Brazil
10.2.1. Brazil MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
10.2.2. Brazil MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
10.3. Mexico
10.3.1. Mexico MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
10.3.2. Mexico MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
10.4. Rest of Latin America
10.4.1. Rest of Latin America MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
10.4.2. Rest of Latin America MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa MRI-Guided Neurosurgical Ablation Market By Country
11.1. Middle East & Africa MRI-Guided Neurosurgical Ablation Market Overview
11.2. GCC
11.2.1. GCC MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
11.2.2. GCC MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
11.3. South Africa
11.3.1. South Africa MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
11.3.2. South Africa MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By Product, 2020-2032
11.4.2. Rest of Middle East & Africa MRI-Guided Neurosurgical Ablation Revenue (USD Million) and Forecast By End Use, 2020-2032
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of MRI-Guided Neurosurgical Ablation Market
12.1. MRI-Guided Neurosurgical Ablation Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global MRI-Guided Neurosurgical Ablation Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Hitachi Medical Systems
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Million), 2023
13.1.3.2. Hitachi Medical Systems 2023 MRI-Guided Neurosurgical Ablation Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. AngioDynamics
13.3. Varian Medical Systems
13.4. Abbott Laboratories
13.5. MRI Interventions, Inc.
13.6. Boston Scientific Corporation
13.7. MR Solutions
13.8. Monteris Medical
13.9. InSightec Ltd.
13.10. Medtronic
13.11. Elekta AB

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings